J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Published online ahead of print on 1 April 2009 as doi:10.1099/vir.0.010553-0
Journal of General Virology 2009;90:1962.

A more recent version of this article appeared on August 1, 2009 J Gen Virol (2009), DOI 10.1099/vir.0.010553-0
© 2009 Society for General Microbiology
This Article
Right arrow Full Text (Papers in Press[PDF])
Right arrow All Versions of this Article:
vir.0.010553-0v1
90/8/1962    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Damon, I. K.
Right arrow Articles by Karem, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damon, I. K.
Right arrow Articles by Karem, K. S.
Agricola
Right arrow Articles by Damon, I. K.
Right arrow Articles by Karem, K. S.

Evaluation of smallpox vaccines using variola neutralization

Inger K. Damon1,4, Whitni B. Davidson1, Christine M. Hughes1, Victoria A. Olson1, Scott K. Smith1, Robert C. Holman1, Sharon E. Frey2, Frances Newman2, Robert B. Belshe2, Lihan Yan3 and Kevin S. Karem1

1 Centers for Disease Control and Prevention;
2 Saint Louis University School of Medicine;
3 The EMMES Corporation

4 E-mail: iad7{at}cdc.gov

The search for a 'third' generation smallpox vaccine has resulted in the development and characterization of several vaccine candidates. A significant barrier in acceptance is the absence of challenge models showing induction of correlates of protective immunity against Variola virus. In this light, virus neutralization provides one of few experimental methods to show specific in vivo activity of vaccines against Variola virus. Here we provide characterization of the ability of a Modified Vaccinia Ankara (MVA) vaccine to induce variola neutralizing antibodies, and we provide comparison to that elicited by standard Dryvax vaccination.

Received 23 January 2009; accepted 28 March 2009.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2009 by the Society for General Microbiology.